Shine Medical Technologies has acquired an exclusive license for a patented hydrogen isotope separation process used in the production of medical isotopes.
The technology belongs to Savannah River Nuclear Solutions (SRNS), the management and operating contractor for the U.S. Department of Energy's Savannah River National Laboratory (SRNL).
The agreement covers the use of the laboratory's thermal cycling absorption process, which provides the high-purity inputs needed for Shine's patented technology for the production of medical isotopes, including molybdenum-99 (Mo-99).
Shine will build its first medical isotope manufacturing facility in Janesville, WI, with the goal of producing enough Mo-99 every year to supply more than two-thirds of the U.S. patient population.
